Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

535268

registered interest
date	11/07/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Internet
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to restrict the quantities of drugs which can be bought from online pharmacies.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	42442
answer	answer is ministerial correction date of answer 14/07/2016 answer text <p>There are no plans for additional controls on the quantities of drugs which can be bought from online pharmacies. In the United Kingdom, there are strict legal controls on the retail sale, supply and advertisement of medicinal products. These legal controls apply equally to medicines sold or supplied via the internet or e-mail transactions. Under medicines legislation, it is unlawful for medicinal products for human use to be marketed, manufactured, imported from a third country, distributed and sold or supplied in the UK except in accordance with the appropriate licences or exemptions. Prescription only and pharmacy medicines may only be legally sold or supplied by or under the supervision of a pharmacist on registered pharmacy premises. In addition, prescription only medicines may only be dispensed against a prescription written by a doctor, dentist or independent prescriber. There are also controls on quantities of certain pharmacy medicines that can be sold or supplied and that applies if the medicine is sold in a pharmacy or online.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 14/07/2016 07:44:15 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones

224734

registered interest
date	03/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Greater Manchester
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential effect of devolution of spending to Greater Manchester on (a) patients who live outside the Greater Manchester area but who are registered with a GP there and (b) patients who wish to receive treatment at a hospital in Greater Manchester but who live outside the area.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	226124
answer	answer is ministerial correction date of answer 06/03/2015 answer text <p>This is a historic partnership between local organisations in Greater Manchester (GM), with general practitioners as clinical leaders working with elected leaders to improve services for people living in the area.</p><p> </p><p> </p><p> </p><p>The National Health Service bodies involved, including NHS England and the relevant clinical commissioning groups, will remain statutorily accountable for the exercise of their functions. GM will work collaboratively with local non-GM bodies and take into account the impact of GM decisions upon non-GM bodies and their communities.</p><p> </p><p> </p><p> </p><p>The fundamental national policies including Choice, inspection regimes, guidance and regulations will continue to apply to GM but, in line with the Five Year Forward View published by NHS England, GM will exercise greater freedom in how they are implemented so that local services better reflect the priorities of local patients and service users.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 06/03/2015 14:37:14 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones

179622

registered interest
date	12/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medicine: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the total amount spent from government sources on research into (a) stroke, (b) cancer and (c) coronary heart disease.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	224370
answer	answer is ministerial correction date of answer 23/02/2015 answer text <p>Spend on research funded directly by the National Institute for Health Research (NIHR) is categorised by Health Research Classification System health categories. NIHR expenditure on research infrastructure and systems where spend cannot be attributed to health categories is excluded. In 2013/14, the NIHR spent £26.3 million in the category ‘stroke’, £129.9 million in the category ‘cancer’, and £46.3 million in the category ‘cardiovascular’ (including coronary heart disease - CHD).</p><p> </p><p> </p><p> </p><p>Research Councils UK has provided the following information on expenditure in 2013/14.</p><p> </p><p> </p><p> </p><p><em>£000s</em></p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Stroke</p></td><td><p>Cancer</p></td><td><p>CHD</p></td></tr><tr><td><p>Arts and Humanities Research Council</p></td><td><p>-</p></td><td><p>34</p></td><td><p>-</p></td></tr><tr><td><p>Biotechnology and Biological Sciences Research Council (BBSRC)</p></td><td><p>323</p></td><td><p>10,269</p></td><td><p>1,829</p></td></tr><tr><td><p>Economic and Social Research Council</p></td><td><p>1,376</p></td><td><p>2,177</p></td><td><p>1,205</p></td></tr><tr><td><p>Engineering and Physical Sciences Research Council (EPSRC)</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td></tr><tr><td><p>Medical Research Council (MRC)</p></td><td><p>4,140</p></td><td><p>79,900</p></td><td><p>26,300</p></td></tr><tr><td><p>Natural Environment Research Council</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td></tr><tr><td><p>Science and Technology Facilities Council (STFC)</p></td><td><p>-</p></td><td><p>395</p></td><td><p>-</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The BBSRC does not fund research directly relating to understanding/treating specific human diseases. The underpinning health research that the BBSRC supports seeks to provide a better understanding of what makes a healthy biological system - and the key moderators of this health (both positive and negative) – and also informs strategies to help maintain resilient health across the life-course and reduce the risk of emergence of diseases typically associated with age-related health decline. In the context of stroke/cardiovascular disease (CVD) and cancer this may include basic bioscience of angiogenesis/tissue repair, inflammation, cell cycle/signalling/molecular transport, and immune system functioning, and how these processes operate and are influenced (e.g. by genetics and environmental factors such as diet and exercise) across the lifecourse. The BBSRC figures provided are based on examples where specific linkages can be made from the basic bioscience to potential applicability to stroke/CVD and cancer research, but there will be a wider body of more indirectly linked bioscience that may also contribute to developing important baseline understanding.</p><p> </p><p> </p><p> </p><p>The EPSRC invested £59 million in 2013/14 in research to develop new technologies that have applications across healthcare from diagnosis and treatment to rehabilitation, and also supports a much wider portfolio of research that underpins advances in medical science. The EPSRC supports basic research which delivers new techniques and technologies, ultimately delivering solutions that underpin the healthcare and life sciences sector, including the pharmaceutical and medical technology industries and the National Health Service. Around 25% of the £4 billion EPSRC portfolio is of relevance to healthcare and the life sciences.</p><p> </p><p> </p><p> </p><p>MRC cancer research expenditure shown in the table is taken from National Cancer Research Institute data for 2013.</p><p> </p><p> </p><p> </p><p>In addition to the expenditure shown in the table, the STFC also makes support available through its large facilities. For instance, cancer-related research is carried out using ALICE (A Large Ion Collider Experiment) in support of the University of Liverpool, who have an EPSRC grant. The grant pays the marginal staff cost and the running cost of the ALICE facility.</p><p> </p><p> </p><p> </p><p>In 2013/14 Innovate UK, the UK’s innovation agency has invested in research concerning stroke, cancer and CHD. The following table details spend for each condition. Figures include research into detection technologies and post-surgery therapies.</p><p> </p><p> </p><p> </p><p><em>£000s</em></p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Stroke</p></td><td><p>Cancer</p></td><td><p>CHD</p></td></tr><tr><td><p>Innovate UK</p></td><td><p>972</p></td><td><p>18,728</p></td><td><p>345</p></td></tr></tbody></table><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 23/02/2015 16:14:19 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones

179175

registered interest
date	11/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Strokes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what funding is provided from government sources for research into (a) intracerebral haemorrhage and (b) subarachnoid haemorrhage.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	224224
answer	answer is ministerial correction date of answer 23/02/2015 answer text <p>The Department’s National Institute for Health Research (NIHR) funds extensive research on stroke and spent £26.3 million in this area in 2013/14.</p><p> </p><p> </p><p> </p><p>Details of research projects funded through programmes managed by the NIHR, including projects relating to stroke, can be found on the NIHR website at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nihr.ac.uk/research/programme-studies.htm" target="_blank">http://www.nihr.ac.uk/research/programme-studies.htm</a></p><p> </p><p> </p><p> </p><p>Details of current and completed research training and career development awards funded by the NIHR, including awards relating to stroke, can be found on the NIHR website at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nihr.ac.uk/research/career-development-awards-funded.htm" target="_blank">http://www.nihr.ac.uk/research/career-development-awards-funded.htm</a></p><p> </p><p> </p><p> </p><p>Details of stroke research studies hosted by the NIHR Clinical Research Network can be found on the UK Clinical Research Network portfolio database at:</p><p> </p><p> </p><p> </p><p><a href="http://england.ukcrn.org.uk/Portfolio.aspx?Level1=6" target="_blank">http://england.ukcrn.org.uk/Portfolio.aspx?Level1=6</a></p><p> </p><p> </p><p> </p><p>Details of current and recent research projects relating to stroke funded by Research Councils and Innovate UK can be found on the Research Councils UK Gateway to Research available at:</p><p> </p><p> </p><p> </p><p><a href="http://gtr.rcuk.ac.uk/" target="_blank">http://gtr.rcuk.ac.uk</a></p><p> </p><p> </p><p> </p><p><strong>The Medical Research Council (MRC) spends around £4.1 million a year on research into stroke.</strong></p><p> </p><p> </p><p> </p><p><strong>Projects recently funded by the MRC include research at the University of Birmingham into the use of motorised jointed levers attached to the patient’s arm or hand to improve upper limb function in stroke survivors, research at University College London on language impairment and recovery after stroke, and research at the University of Edinburgh into how the function of the protein TREM-2 influences the balance between toxic and protective inflammation that occurs as a result of stroke.</strong></p><p> </p><p> </p><p> </p><p>Some Government-funded projects in stroke have relevance to intracerebral haemorrhage (ICH) and subarachnoid haemorrhage (SAH).</p><p> </p><p> </p><p> </p><p>The NIHR Health Technology Assessment programme is funding a £2.5 million trial of tranexamic acid for hyperacute primary ICH, and a £1.3 million surgical trial in traumatic ICH.</p><p> </p><p> </p><p> </p><p>The NIHR Oxford Biomedical Research Centre has a research sub-theme on acute vascular syndromes including SAH.</p><p> </p><p><strong> </strong></p><p> </p><p>The MRC is funding research in Oxford investigating the genetic contribution to ICH. This project uses the China Kadoorie Biobank study of 0.5 million people to investigate 5,000 confirmed cases of ICH and 10,000 controls, in order to identify genetic variants linked to ICH.</p><p> </p><p><strong> </strong></p><p> </p><p><strong>The MRC is also funding research in Oxford investigating the impact of early brain injury on outcomes after SAH using magnetic resonance imaging, and in Manchester investigating how to reduce the incidence of delayed cerebral ischaemia following SAH.</strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 224225 question first answered 23/02/2015 16:31:59 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones

179177

registered interest
date	11/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Strokes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what stroke research projects receive funding from (a) his Department and (b) other government sources.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	224225
answer	answer is ministerial correction date of answer 23/02/2015 answer text <p>The Department’s National Institute for Health Research (NIHR) funds extensive research on stroke and spent £26.3 million in this area in 2013/14.</p><p> </p><p> </p><p> </p><p>Details of research projects funded through programmes managed by the NIHR, including projects relating to stroke, can be found on the NIHR website at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nihr.ac.uk/research/programme-studies.htm" target="_blank">http://www.nihr.ac.uk/research/programme-studies.htm</a></p><p> </p><p> </p><p> </p><p>Details of current and completed research training and career development awards funded by the NIHR, including awards relating to stroke, can be found on the NIHR website at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nihr.ac.uk/research/career-development-awards-funded.htm" target="_blank">http://www.nihr.ac.uk/research/career-development-awards-funded.htm</a></p><p> </p><p> </p><p> </p><p>Details of stroke research studies hosted by the NIHR Clinical Research Network can be found on the UK Clinical Research Network portfolio database at:</p><p> </p><p> </p><p> </p><p><a href="http://england.ukcrn.org.uk/Portfolio.aspx?Level1=6" target="_blank">http://england.ukcrn.org.uk/Portfolio.aspx?Level1=6</a></p><p> </p><p> </p><p> </p><p>Details of current and recent research projects relating to stroke funded by Research Councils and Innovate UK can be found on the Research Councils UK Gateway to Research available at:</p><p> </p><p> </p><p> </p><p><a href="http://gtr.rcuk.ac.uk/" target="_blank">http://gtr.rcuk.ac.uk</a></p><p> </p><p> </p><p> </p><p><strong>The Medical Research Council (MRC) spends around £4.1 million a year on research into stroke.</strong></p><p> </p><p> </p><p> </p><p><strong>Projects recently funded by the MRC include research at the University of Birmingham into the use of motorised jointed levers attached to the patient’s arm or hand to improve upper limb function in stroke survivors, research at University College London on language impairment and recovery after stroke, and research at the University of Edinburgh into how the function of the protein TREM-2 influences the balance between toxic and protective inflammation that occurs as a result of stroke.</strong></p><p> </p><p> </p><p> </p><p>Some Government-funded projects in stroke have relevance to intracerebral haemorrhage (ICH) and subarachnoid haemorrhage (SAH).</p><p> </p><p> </p><p> </p><p>The NIHR Health Technology Assessment programme is funding a £2.5 million trial of tranexamic acid for hyperacute primary ICH, and a £1.3 million surgical trial in traumatic ICH.</p><p> </p><p> </p><p> </p><p>The NIHR Oxford Biomedical Research Centre has a research sub-theme on acute vascular syndromes including SAH.</p><p> </p><p><strong> </strong></p><p> </p><p>The MRC is funding research in Oxford investigating the genetic contribution to ICH. This project uses the China Kadoorie Biobank study of 0.5 million people to investigate 5,000 confirmed cases of ICH and 10,000 controls, in order to identify genetic variants linked to ICH.</p><p> </p><p><strong> </strong></p><p> </p><p><strong>The MRC is also funding research in Oxford investigating the impact of early brain injury on outcomes after SAH using magnetic resonance imaging, and in Manchester investigating how to reduce the incidence of delayed cerebral ischaemia following SAH.</strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 224224 question first answered 23/02/2015 16:31:59 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones

178515

registered interest
date	09/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Strokes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the report Research spend in the UK, published by the Stroke Association on 3 December 2014, what assessment he has made of the implications for his policies of the findings of that report; and if he will make a statement.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	223841
answer	answer is ministerial correction date of answer 12/02/2015 answer text <p>The report published by the Stroke Association compares research spend in four disease areas (stroke, cancer, coronary heart disease and dementia) by governmental organisations and charities.</p><p> </p><p> </p><p> </p><p>The usual practice of the two main public funders of health research – the Department’s National Institute for Health Research (NIHR) and the Medical Research Council (MRC) - is not to ring-fence funds for expenditure on particular topics or disease areas: research proposals in all areas compete for the funding available.</p><p> </p><p> </p><p> </p><p>NIHR expenditure on research on stroke, cancer, cardiovascular disease (CVD) (including coronary heart disease) and dementia is shown in the following table.</p><p> </p><p> </p><p> </p><p>£ million</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>Stroke</p></td><td><p>20.2</p></td><td><p>20.9</p></td><td><p>20.4</p></td><td><p>26.1</p></td><td><p>26.3</p></td></tr><tr><td><p>Cancer</p></td><td><p>101.5</p></td><td><p>100.9</p></td><td><p>104.1</p></td><td><p>133.2</p></td><td><p>129.9</p></td></tr><tr><td><p>CVD</p></td><td><p>31.6</p></td><td><p>31.0</p></td><td><p>34.1</p></td><td><p>42.7</p></td><td><p>46.3</p></td></tr><tr><td><p>Dementia</p></td><td><p>12.6</p></td><td><p>18.3</p></td><td><p>24.9</p></td><td><p>24.4</p></td><td><p>26.8</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Through its training and career development programmes, the NIHR supports clinicians at all stages of their career: integrated clinical and academic training; doctoral training; postdoctoral training; and more senior awards. The prestigious NIHR Senior Investigator award provides an additional incentive for the country’s most outstanding clinical researchers. These programmes make a major contribution to the building and developing of research capacity in stroke and other disease areas.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 223831 223849 question first answered 12/02/2015 16:58:59 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones

178517

registered interest
date	09/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Strokes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to increase the number of patients involved in stroke research trials.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	223832
answer	answer is ministerial correction date of answer 23/02/2015 answer text <p>The National Institute for Health Research (NIHR) Clinical Research Network (CRN) makes it possible for patients to participate in relevant research. The CRN supports the set-up and timely delivery of commercial and non-commercial trials and studies in the National Health Service in England. The number of CRN-hosted studies in stroke as main specialty, and recruitment to these studies, has increased substantially since 2008/09.</p><p> </p><p> </p><p> </p><p>Data on the number of CRN trials (phases I to IV) and other well-designed studies open in each year in stroke, and recruitment to these trials and studies is shown in the following table.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2008/09</p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>Number of trials</p></td><td><p>33</p></td><td><p>47</p></td><td><p>43</p></td><td><p>37</p></td><td><p>35</p></td><td><p>39</p></td></tr><tr><td><p>Number of studies (including trials)</p></td><td><p>66</p></td><td><p>98</p></td><td><p>105</p></td><td><p>117</p></td><td><p>115</p></td><td><p>114</p></td></tr><tr><td><p>Recruitment in trials</p></td><td><p>2,632</p></td><td><p>3,259</p></td><td><p>4,372</p></td><td><p>5,061</p></td><td><p>4,512</p></td><td><p>3,015</p></td></tr><tr><td><p>Recruitment in studies (including trials)</p></td><td><p>6,995</p></td><td><p>7,635</p></td><td><p>10,517</p></td><td><p>11,979</p></td><td><p>12,373</p></td><td><p>9,306</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Recruitment to stroke studies was lower in 2013/14 than in 2012/13 as several large multi-centre studies with high recruitment targets closed. In addition, there has been change in the overall composition of the stroke study portfolio, with an increased number of single-centre and earlier phase studies with smaller recruitment targets.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 23/02/2015 16:42:54 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones

178518

registered interest
date	09/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Strokes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will increase spending on stroke research to the same level as the spending on cancer and coronary heart disease research.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	223831
answer	answer is ministerial correction date of answer 12/02/2015 answer text <p>The report published by the Stroke Association compares research spend in four disease areas (stroke, cancer, coronary heart disease and dementia) by governmental organisations and charities.</p><p> </p><p> </p><p> </p><p>The usual practice of the two main public funders of health research – the Department’s National Institute for Health Research (NIHR) and the Medical Research Council (MRC) - is not to ring-fence funds for expenditure on particular topics or disease areas: research proposals in all areas compete for the funding available.</p><p> </p><p> </p><p> </p><p>NIHR expenditure on research on stroke, cancer, cardiovascular disease (CVD) (including coronary heart disease) and dementia is shown in the following table.</p><p> </p><p> </p><p> </p><p>£ million</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>Stroke</p></td><td><p>20.2</p></td><td><p>20.9</p></td><td><p>20.4</p></td><td><p>26.1</p></td><td><p>26.3</p></td></tr><tr><td><p>Cancer</p></td><td><p>101.5</p></td><td><p>100.9</p></td><td><p>104.1</p></td><td><p>133.2</p></td><td><p>129.9</p></td></tr><tr><td><p>CVD</p></td><td><p>31.6</p></td><td><p>31.0</p></td><td><p>34.1</p></td><td><p>42.7</p></td><td><p>46.3</p></td></tr><tr><td><p>Dementia</p></td><td><p>12.6</p></td><td><p>18.3</p></td><td><p>24.9</p></td><td><p>24.4</p></td><td><p>26.8</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Through its training and career development programmes, the NIHR supports clinicians at all stages of their career: integrated clinical and academic training; doctoral training; postdoctoral training; and more senior awards. The prestigious NIHR Senior Investigator award provides an additional incentive for the country’s most outstanding clinical researchers. These programmes make a major contribution to the building and developing of research capacity in stroke and other disease areas.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 223841 223849 question first answered 12/02/2015 16:58:59 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones

178562

registered interest
date	09/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Strokes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to improve stroke research capacity in the UK.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	223849
answer	answer is ministerial correction date of answer 12/02/2015 answer text <p>The report published by the Stroke Association compares research spend in four disease areas (stroke, cancer, coronary heart disease and dementia) by governmental organisations and charities.</p><p> </p><p> </p><p> </p><p>The usual practice of the two main public funders of health research – the Department’s National Institute for Health Research (NIHR) and the Medical Research Council (MRC) - is not to ring-fence funds for expenditure on particular topics or disease areas: research proposals in all areas compete for the funding available.</p><p> </p><p> </p><p> </p><p>NIHR expenditure on research on stroke, cancer, cardiovascular disease (CVD) (including coronary heart disease) and dementia is shown in the following table.</p><p> </p><p> </p><p> </p><p>£ million</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>Stroke</p></td><td><p>20.2</p></td><td><p>20.9</p></td><td><p>20.4</p></td><td><p>26.1</p></td><td><p>26.3</p></td></tr><tr><td><p>Cancer</p></td><td><p>101.5</p></td><td><p>100.9</p></td><td><p>104.1</p></td><td><p>133.2</p></td><td><p>129.9</p></td></tr><tr><td><p>CVD</p></td><td><p>31.6</p></td><td><p>31.0</p></td><td><p>34.1</p></td><td><p>42.7</p></td><td><p>46.3</p></td></tr><tr><td><p>Dementia</p></td><td><p>12.6</p></td><td><p>18.3</p></td><td><p>24.9</p></td><td><p>24.4</p></td><td><p>26.8</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Through its training and career development programmes, the NIHR supports clinicians at all stages of their career: integrated clinical and academic training; doctoral training; postdoctoral training; and more senior awards. The prestigious NIHR Senior Investigator award provides an additional incentive for the country’s most outstanding clinical researchers. These programmes make a major contribution to the building and developing of research capacity in stroke and other disease areas.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 223831 223841 question first answered 12/02/2015 16:59:00 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones

101149

registered interest
date	27/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Asthma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent representations he has received on extending the right to free prescriptions to all asthma patients; and if he will make a statement.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	212053
answer	answer is ministerial correction date of answer 30/10/2014 answer text <p>We are unable to make such an estimate.</p><p> </p><p> </p><p> </p><p>Data on the cost to the National Health Service of treating asthma patients in accident and emergency or unplanned hospital admissions is not collected by the Department. The Health and Social Care Information Centre (HSCI) has published information on reasons, for example respiratory problems, for accident and emergency attendance in its <em>Hospital Episode Statistics: Accident and Emergency Attendances in England 2012-13</em>, but this does not identify specific conditions, such as asthma, that may have prompted an accident and emergency visit or unplanned hospital admission.</p><p> </p><p> </p><p> </p><p>Since 1 November 2013, the Department has received 44 representations through the Department’s Ministerial correspondence unit and two parliamentary questions, including the hon. Member’s own, regarding extending exemption from prescription charging to people with asthma.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 212052 question first answered 30/10/2014 16:45:13 answering member 4020 label Biography information for George Freeman
tabling member	432 label Biography information for Helen Jones